Find a Physician

Return to Research Overview

More on Research

Health Information

Return to Research Overview

More on Research

Research and Clinical Trials

Return to Research Overview

More on Research

For Patients, Families & Visitors

Return to Research Overview

More on Research

Professionals

Return to Research Overview

More on Research

Hospital News

Return to Research Overview

More on Research

Cardiomyopathy, Heart Failure and Transplantation Program

Research

Molecular Diagnostic Laboratory

Wendy Chung, MD, PhD, Director

The Molecular Diagnostic Laboratory performs research to identify the underlying genetic basis for inherited susceptibilities to cardiomyopathy, as well as investigates genetic and environmental determinants for response to therapy, prognosis, and risk of arrhythmias. Several projects are ongoing and include:

  • Identify new genetic etiologies for cardiomyopathy in children.
  • Characterize the type and frequency of mutations in gene associated with cardiomyopathy in children of different ages.
  • Identify genetic factors that modify the severity and progression of ventricular dysfunction and arrhythmias in children with cardiomypathy.

Pediatric Heart Transplant Study Registry

Linda J. Addonizio, MD, Director

The primary purpose of this study is to identify risk factors for certain outcomes (mortality, retransplant, coronary artery disease, rejection, and infection) in pediatric heart transplant patients in order to advance the state of knowledge regarding pediatric heart transplant. All patients less than 18 years old who are listed for cardiac transplant with UNOS through our institution are enrolled in this registry.

Pediatric Cardiomyopathy Registry

Linda J. Addonizio, MD, Principal Investigator

The Pediatric Cardiomyopathy Registry is an ongoing registry funded by the National Institutes of Health and the National Heart, Lung, and Blood Institute. Its purpose is to describe the epidemiologic features and clinical course of selected cardiomyopathies in patients aged 18 years or younger and to promote the development of etiology-specific treatments.

Contact

Pediatric Cardiomyopathy, Heart Failure and Transplantation
Directions
(212) 305-6575
  • Bookmark
  • Print


Top of page